Cited by 7Schizophrenia research and treatmentGrowth Hormone and Insulin-like Growth FactorsRegulation of Appetite and Obesity

Postprandial prolactin suppression appears absent in antipsychotic-treated male patients

Open access
Coello, Klara, Broberg, Brian V., Bak, Nikolaj, Madsen, Anna, Mortensen, Henrik B., Søgaard, Birgitte, Szecsi, Pal B., Knop, Filip K. +2 more·2015·Psychoneuroendocrinology

Abstract

INTRODUCTION: Hyperprolactinemia is a common side-effect of antipsychotic treatment. Antipsychotics and hyperprolactinemia are both considered risk factors of metabolic disturbances and diabetes. Investigations on prolactin response to meal ingestion in antipsychotic-treated patients are missing. MATERIAL AND METHODS: In a case-control design, 49 antipsychotic-treated, clinically stable, non-diabetic, schizophrenia spectrum male patients were compared with 93 healthy male controls by age (33.1, SD 7.4 vs. 32.9, SD 6.6 years), body mass index (26.2, SD 4.6 vs. 26.1, SD 3.9 kg/m(2)) and waist circumference (96.4, SD 13.0 vs. 96.7, SD 11.9 cm). Serum-prolactin was measured in the morning and 90 min after ingestion of a standardized liquid meal (2268 kJ). RESULTS: Fasting prolactin levels varied considerably, and mean fasting prolactin levels did not significantly differ between patients and controls (12.33, SD 11.58 vs. 10.06, SD 8.67 ng/ml, p = 0.623). In the controls, postprandial serum prolactin was significantly reduced (Δ -2.53, SD 9.75 ng/ml, p = 0.016). In antipsychotic-treated patients postprandial serum prolactin tended to increase (Δ 2.62, SD 10.96 ng/ml, p = 0.081). Analyses of subgroups based on the prolactinogenic liability of their antipsychotic treatment indicated 22 to 65% higher postprandial prolactin levels with high and intermediate prolactinogenic antipsychotics. DISCUSSION: A physiological postprandial suppression of serum prolactin appears absent in antipsychotic-treated males. Marked variability in fasting prolactin levels may reflect individual variations in the diurnal cycle. Uniform acquisition procedures accounting for diurnal variation and food intake may enhance reliability of prolactin levels in antipsychotic-treated male patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.psyneuen.2015.05.014

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. McKeage, K., Plosker, G.L., 2004. Amisulpride: a review of its use in the management of schizophrenia. CNS Drugs 18, 933-956.

Cited by

Sorted by citations

Authors
Coello, K., Broberg, B. V., Bak, N., Madsen, A., Mortensen, H. B., Søgaard, B., Szecsi, P. B., Knop, F. K., Lublin, H., & Ebdrup, B. H.
Affiliations
  • Mental Health Services (DK)
  • University of Copenhagen (DK)
  • Lundbeck (Denmark) (DK)
Corresponding author
Ebdrup, Bjørn H.
Venue
Psychoneuroendocrinology
Publisher
Elsevier BV
Published
2015-10
Volume
60
Pages
1-6
ISSN
0306-4530 (ISSN-L)
OpenAlex
W1829522620
Cited by
7
References
15
Citations by year
2024: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2015: 1
FWCI
0.81
Type
journal article
Language
en
Open access
Locations
  • Psychoneuroendocrinology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
Funders
  • Lundbeckfonden (R155-2013-16337, R25-A2701)
  • Region Hovedstaden (R25-A2701)
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
antipsychotic drugs, hyperprolactinemia, schizophrenia spectrum, meal ingestion, diurnal variation, metabolic disorders, diabetes risk
MeSH terms
Adult, Humans, Hyperprolactinemia, Male, Middle Aged, Prolactin, Risk Factors, Schizophrenia, Antipsychotic Agents, Body Mass Index, Case-Control Studies, Postprandial Period, Waist Circumference, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review